论文部分内容阅读
目的研究分析采用贝那普利+氨氯地平对难治性高血压治疗的疗效。方法选取本院2014年1月-2016年12月收治的难治性高血压患者255例为研究对象,分为两组,B组以贝那普利治疗(n=127),A组在B组基础上联合氨氯地平治疗(n=128),分别比较两组药物治疗疗效。结果治疗前两组高血压患者舒张压和收缩压水平无较大差异(P>0.05),而治疗组A组患者血压水平改善情况优于B组(P>0.05);A组高血压患者治疗总疗效优于B组(P>0.05)。结论将贝那普利+氨氯地平治疗难治性高血压的临床疗效显著,患者的血压水平得到有效控制。
Objective To study the effect of benazepril and amlodipine on the treatment of refractory hypertension. Methods A total of 255 refractory patients with hypertension were selected from January 2014 to December 2016 in our hospital. Patients in group B were treated with benazepril (n = 127), while those in group B Group based on the combination of amlodipine treatment (n = 128), respectively, compared the efficacy of two groups of drug treatment. Results There was no significant difference in diastolic blood pressure and systolic blood pressure between the two groups before treatment (P> 0.05), while the improvement of blood pressure in group A was better than that of group B (P> 0.05). The treatment of hypertension in group A The total curative effect was better than that of group B (P> 0.05). Conclusion The clinical efficacy of benazepril plus amlodipine in the treatment of refractory hypertension is significant, and the patient’s blood pressure level is effectively controlled.